1. Детская гематология/ Под ред: А.Г. Румянцева, А.А. Масчана, Е.В. Жуковской. Авторы :Айзенберг В.Л., Балашов Д.Н., Биккулова Д.Ш., Вдовин В.В., Володин Н.Н., Демихов В.Г., Демихова Е.В., Евдокимова М.А., Жарков П.А., Журина, О.Н., Зозуля Н.И., Инякова Н.В., Карачунский А.И., Клипинина Н.В., Копылов К.Г., Кузминова Ж.А., Кумирова Э.В., Кумскова М.А., Лазарев В.В., Луговская С.А., Лукина Е.А., Лунякова Е.А., Масчан М.А., Морщакова Е.Ф., Мякова Н.В., Новичкова Г.А., Орлов А.Б., Панкратьева Л.Л., Полевиченко Е.В., Птушкин В.В., Румянцева Ю.В., Самочатова Е.В., Свирин П.В., Сигарева И.А., Скворцова Ю.В., Скобин В.Б., Сметанина Н.С., Спиридонова Е.А., Стефаненко Е.А., Тарасова И.С., Хаин А.Е., Хамин И.Г., Харькин А.В., Хачатрян Л.А., Цветаева Н.В., Цыпин Л.Е., Чернов В.М., Щербина А.Ю., Щукин В.В.// Москва. Издательская группа « ГЭОТАР- Медиа» 2015 г. С. - 656.
2. Arber D.A., Brunning R.D., LeBeau М.М. et al. Acute myeloid leukaemia with recurrent genetic abnormalities // WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. / Eds S.H. Swerdlow, E. Campo, N.L. Harris et al. — Lyon: IARC Press, 2008. — P. 110-123.
3. Arber D.A., Brunning R.D., Orazi A. et al. Acute myeloid leukaemia with myelodysplasia-related changes // WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. / Eds S.H. Swerdlow, E. Campo, N.L. Harris etal. — Lyon: IARC Press, 2008. — P. 124-129.
4. Arber D.A., Brunning R.D., Orazi A. et al. Acute myeloid leukemia, not otherwise specified // WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. / Eds S.H. Swerdlow, E. Campo, N.L. Harris et al. — Lyon: IARC Press, 2008. — P. 130-139. Google Scholar
5. Baumann I., Niemeyer C.M., Brunning R.D. et al. Myeloid proliferations related to Down syndrome // WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. / Eds S.H. Swerdlow, E. Campo, N.L. Harris et al. - Lyon: IARC Press, 2008. - P. 142-144.
6. Vardiman J.W., Arber D.A., Brunning R.D. et al. Therapy-related myeloid neoplasms // WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. / Eds S.H. Swerdlow, E. Campo, N.L. Harris et al. — Lyon: IARC Press, 2008,- P. 127-129.
7. Heerema-McKenney A. Arber D.A. Acute myeloid leukemia // Hematol. Oncol. Clin. North Am. - 2009. - Vol. 23. - P. 633-654.
8. Szczepanski Т., Harrison C.J., van Dongen J.J. Genetic aberrations in paediatric acute leukaemias and implications for management of patients // Lancet Oncol. - 2010, Sep. - Vol. 11, N 9. - P. 880-889.
9. Ross M.E., Mahfouz R., Onciu M. et al. Gene expression profiling of pediatric acute myelogenous leukemia // Blood. — 2004, Dec 1. — Vol. 104, N 12. — P. 3679-3687.
10. Creutzig U., Zimmermann М., Dworzak M.N. et al. The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01 // Haematologica. — 2014, Sep. — Vol. 99, N 9. - Р. 1472-1478. doi: 10.3324/haematol.2014.104182. Epub 2014 Apr 24.
11. Kaspers G.J., Zimmermann М., Reinhardt D. et al. Improved outcome in pediatric relapsed acute myeloid leukemia: resultsof a randomized trial on liposomal daunorubicin by the International BFM Study Group // J. Clin. Oncol. — 2013 Feb 10. - Vol. 31, N 5. - P. 599-607.
12. Creutzig U., van den Heuvel-Eibrink M.M., Gibson B. et al. AML Committee of the International BFM Study Group. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel//Blood. — 2012, Oct 18,— Vol. 120, N 16. — P. 3187— 3205. doi: 10.1182/blood-2012-03-362608.
13. Klusmann J.H., Reinhardt D., Zimmermann M. et al. The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study // Haematologica. — 2012, Jan.-Vol. 97, N 1,-P. 21-29.
14. Von NeuhoffC.. Reinhardt D.,Sander A. etal. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98 // J. Clin. Oncol. — 2010 Jun I.-Vol. 28, N 16. - P. 2682-2689.
15. EhlcrsS., Herbst C., Zimmermann M. etal. Granulocyte colonystimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse //J. Clin. Oncol. — 2010, May 20. — Vol. 28, N 15. - P. 2591-2597. doi: 10.1200/JC0.2009.25.9010.
16. Lehrnbecher Т., Kaiser J., Varwig D. et al. Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93 // Eur. J. Clin. Microbiol. Infect. Dis. — 2007, Oct. - Vol. 26, N 10. - P. 735-738.
17. Creutzig U., Zimmermann М., Lehrnbecher T. et al. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colonystimulating factor in children and adolescents with acute myeloid leukemia: results of AML- BFM 98 // J. Clin. Oncol. - 2006, Sep 20. -Vol. 24, N 27. - P. 4499-4506.
18. Creutzig U., Zimmermann М., Reinhardt D. et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98 // J. Clin. Oncol. - 2004, Nov 1. - Vol. 22, N 21. -P. 4384-4393.
1 9.Oberoi S., Lehrnbecher Т., Phillips B.et al. Leukapheresis and low- dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis // Lcuk. Res. — 2014, Apr. - Vol. 38, N 4. - P. 460-468.
20 .Haase R., Merkel N., Diwan O. et al. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience // Klin. Padiatr. — 2009, Nov-Dee. — Vol. 221, N 6. — P. 374-378.
21 . Creutzig U., Ritter J., Budde M. et al. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia // Cancer. — 1987, Dec 15. — Vol. 60, N 12. — P. 3071-3079.
22 .Perel Y., Auvrignon A., Leblanc Т. et al. French LAME (Leucdmie Aigue Mydloblastique Enfant) Cooperative Group. Treatment of childhood acute niyeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit-multicenter studies of the French LAME (Leucdmie Aigue Mydloblastique Enfant) Cooperative Group // Leukemia. — 2005, Dec. — Vol. 19, N 12.-P. 2082-2089.